The global drug delivery devices market size is expected to reach USD 345.8 billion by 2027, expanding at a CAGR of 6.15% over the forecast period, according to a new report by Grand View Research, Inc. Growing prevalence of cancer, neurological disorders, diabetes, and other infectious diseases is expected to drive the adoption of drug delivery devices in the coming years. In addition, increasing product launches for various applications such as ophthalmology, neurology, and oncology are also expected to propel the market growth. Growing adoption of wearable drug delivery devices for its usage in home-care settings is also expected to drive the market.
Hydrogel
is one of the prominent drug delivery vehicles and includes supramolecular
hydrogels, DNA hydrogels, bio-inspired hydrogels, multi-functional and
stimuli-responsive hydrogels. These advanced hydrogels are used for various
applications such as ophthalmic, oral, intestinal, cardiac illness, and cancer.
Similarly, other vehicles such as liposomes, nanoparticles, and micelle are
also being developed for various applications.
Key
players present in the market are adopting various strategies such as mergers
and acquisitions, partnership, and collaborations to develop and improve drug
delivery devices for various applications. Moreover, end-users are also forming
partnerships with companies to acquire drug delivery devices for training
purpose and research studies. In addition, market players are also forming
distribution agreement to expand the reach of their products. Therefore,
alliances made by the players are expected to drive the market growth during
the forecast period.
For Full Research Report On Drug Delivery Devices Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/drug-delivery-devices-market
Drug Delivery
Devices Market Report Highlights
- The oral route of
administration segment held largest share in 2019 mainly due to its easy
usage and low cost
- The injectable route of
administration segment is expected to experience the fastest growth during
the forecast period mainly due to growing advancements in injectable
devices for accuracy
- Drug delivery devices for
central nervous system disorders are expected to experience fastest growth
rate mainly due to growing development of blood brain barrier drug
delivery devices for the treatment of neurological disorders
- The liposome vehicle held
segment the largest share in 2019 due to its non-toxic nature and
biocompatible design for proper drug delivery
- The nanoparticle vehicle
segment is expected to experience fastest growth rate during the forecast
period mainly because these vehicles can carry various macromolecular
drugs to the affected site for treatment
- In 2019, North America
dominated the global space with the largest revenue share owing to the
adoption of drug delivery devices in the region and increasing product
launches in the countries such as U.S.
- Asia Pacific is expected to
grow at fastest growth rate during the forecast period mainly due to
growing development and advancement in drug delivery devices in the region
and presence of large patient pool.
- Key players in the drug
delivery devices market include Pfizer, Inc.; Johnson & Johnson
Services, Inc.; F. Hoffmann-La Roche, Ltd.; Novartis AG; BD; Bayer AG;
uniQure N.V.; and Sibiono GeneTech Co. Ltd.
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/drug-delivery-devices-market/request/rs1
Drug Delivery
Devices Market Segmentation
Grand View Research has segmented
the global drug delivery devices market based on route of administration,
application, end use, vehicle, and region:
Drug Delivery
Devices Route of Administration Outlook (Volume, Units; Revenue, USD Billion,
2016 - 2027)
- Oral
- Inhalation
- Transdermal
- Injectable
- Ocular
- Nasal
- Topical
- Others
Drug Delivery
Devices Application Outlook (Revenue, USD Billion, 2016 - 2027)
- Oncology
- Infectious Diseases
- Respiratory Diseases
- Diabetes
- Cardiovascular Diseases
- Autoimmune Diseases
- Central Nervous System
Disorders
- Others
Drug Delivery
Devices End-use Outlook (Revenue, USD Billion, 2016 - 2027)
- Hospitals
- Diagnostic Centers
- Ambulatory Surgery
Centers/Clinics
- Home Care Settings
- Others
Drug Delivery
Devices Vehicles Outlook (Volume, Units; Revenue, USD Billion, 2016 - 2027)
- Hydrogel
- Oncology
- Infectious Diseases
- Respiratory Diseases
- Diabetes
- Cardiovascular Diseases
- Autoimmune Diseases
- Central Nervous System
Disorders
- Others
- Micelle
- Oncology
- Infectious Diseases
- Respiratory Diseases
- Diabetes
- Cardiovascular Diseases
- Autoimmune Diseases
- Central Nervous System
Disorders
- Others
- Dendrimer
- Oncology
- Infectious Diseases
- Respiratory Diseases
- Diabetes
- Cardiovascular Diseases
- Autoimmune Diseases
- Central Nervous System
Disorders
- Others
- Nanoparticle
- Oncology
- Infectious Diseases
- Respiratory Diseases
- Diabetes
- Cardiovascular Diseases
- Autoimmune Diseases
- Central Nervous System
Disorders
- Others
- Liposome
- Oncology
- Infectious Diseases
- Respiratory Diseases
- Diabetes
- Cardiovascular Diseases
- Autoimmune Diseases
- Central Nervous System
Disorders
- Others
- Scaffold
- Oncology
- Infectious Diseases
- Respiratory Diseases
- Diabetes
- Cardiovascular Diseases
- Autoimmune Diseases
- Central Nervous System
Disorders
- Others
- Mesoporous Material
- Oncology
- Infectious Diseases
- Respiratory Diseases
- Diabetes
- Cardiovascular Diseases
- Autoimmune Diseases
- Central Nervous System
Disorders
- Others
- Niosomes
- Oncology
- Infectious Diseases
- Respiratory Diseases
- Diabetes
- Cardiovascular Diseases
- Autoimmune Diseases
- Central Nervous System
Disorders
- Others
Drug Delivery
Devices Regional Outlook (Volume, units; Revenue, USD Billion, 2016 - 2027)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- The Netherlands
- Switzerland
- Turkey
- Poland
- Asia Pacific
- China
- Japan
- India
- Thailand
- South Korea
- Indonesia
- Taiwan
- Hong Kong
- Philippines
- Malaysia
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
- Qatar
About Grand View Research
Grand View Research, Inc. is a U.S. based
market research and consulting company, registered in the State of California
and headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment